HUP0400940A2 - Injection formulation for treating skin desaeses caused by human papilloma viruses - Google Patents

Injection formulation for treating skin desaeses caused by human papilloma viruses

Info

Publication number
HUP0400940A2
HUP0400940A2 HU0400940A HUP0400940A HUP0400940A2 HU P0400940 A2 HUP0400940 A2 HU P0400940A2 HU 0400940 A HU0400940 A HU 0400940A HU P0400940 A HUP0400940 A HU P0400940A HU P0400940 A2 HUP0400940 A2 HU P0400940A2
Authority
HU
Hungary
Prior art keywords
desaeses
caused
human papilloma
treating skin
papilloma viruses
Prior art date
Application number
HU0400940A
Other languages
Hungarian (hu)
Inventor
Gyoezoe Dr Szolnoky
Original Assignee
Gyoezoe Dr Szolnoky
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gyoezoe Dr Szolnoky filed Critical Gyoezoe Dr Szolnoky
Priority to HU0400940A priority Critical patent/HU226845B1/en
Publication of HU0400940D0 publication Critical patent/HU0400940D0/en
Publication of HUP0400940A2 publication Critical patent/HUP0400940A2/en
Publication of HU226845B1 publication Critical patent/HU226845B1/en

Links

Abstract

The injection preparation comprises purified freeze-dried tuberculin (1-50 TE/ml) and liquid vehicle, and optionally contains additives. The vehicle is sterilized distilled water, normal saline solution or lidocaine (0.5-1 mass/mass%). ACTIVITY : Dermatological; Virucide. No biological data given. MECHANISM OF ACTION : None given.
HU0400940A 2004-05-06 2004-05-06 Process for the preparation of an injection formulation comprising tuberculin as agent HU226845B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU0400940A HU226845B1 (en) 2004-05-06 2004-05-06 Process for the preparation of an injection formulation comprising tuberculin as agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0400940A HU226845B1 (en) 2004-05-06 2004-05-06 Process for the preparation of an injection formulation comprising tuberculin as agent

Publications (3)

Publication Number Publication Date
HU0400940D0 HU0400940D0 (en) 2004-08-30
HUP0400940A2 true HUP0400940A2 (en) 2006-08-28
HU226845B1 HU226845B1 (en) 2009-12-28

Family

ID=89982200

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0400940A HU226845B1 (en) 2004-05-06 2004-05-06 Process for the preparation of an injection formulation comprising tuberculin as agent

Country Status (1)

Country Link
HU (1) HU226845B1 (en)

Also Published As

Publication number Publication date
HU226845B1 (en) 2009-12-28
HU0400940D0 (en) 2004-08-30

Similar Documents

Publication Publication Date Title
BR9814615A (en) Methods and materials for the treatment and prevention of mucosal tissue inflammation
BR0315598A (en) Neutralizing antibodies to gdf-8 and their uses
ES2193777T3 (en) MICROBIOLOGICALLY STABLE AND INALTERABLE DISSOLUTIONS OF GAMMA-HYDROXIBUTIRATE SALT FOR THE TREATMENT OF NARCOLEPSY.
ATE349511T1 (en) MICROORGANISMS FOR THE TREATMENT OR PREVENTION OF OBESITY AND DIABETES MELLITUS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
BR0001919A (en) Composition of skin cleansing cream so that it forms foam, and a sparkling skin cleaning system.
BR0103256A (en) Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
SE9502167D0 (en) Insulin analog formulations
WO2003075850A3 (en) Methods for alzheimer's disease treatment and cognitive enhancement
SG45225A1 (en) A novel physiologically active substance
WO2006114105A8 (en) Use of modified factor vii for treating bleeding
FR2865651B1 (en) TOPICAL COMPOSITIONS COMPRISING SODIUM HYALURONATE FRAGMENTS AND RETINOID USEFUL IN COSMETIC AND MEDICAL DERMATOLOGY
BRPI9910024B8 (en) use of a mixture of sugar alcohols containing 6-o-alpha-d-glycopyranosyl-d-sorbitol (1,6-gps) and 1-o-alpha-d-glycopyranosyl-d-mannitol (1,1-gpm) in vitro, and pharmaceutical composition for human or animal consumption
SE0102147D0 (en) New methods
BR0314533A (en) System for supplying useful substance to human body in a sauna space
EP2261260A3 (en) Methods for inducing autolysis in infectious bacteria
CN102988962B (en) A kind of complex for preventing or treat skin pruritus
HUP0400940A2 (en) Injection formulation for treating skin desaeses caused by human papilloma viruses
BR0017340A (en) Treatment of trauma and other indications
Sada et al. Necrotizing fasciitis and myonecrosis “synergistic necrotizing cellulitis” caused by Bacillus cereus
RU2006109966A (en) YANTASTIM-S DRUG FOR THERAPY AND PREVENTION OF ANIMAL INFECTIOUS DISEASES
DE60209355D1 (en) COSMETIC PREPARATION AGAINST HAINFALTEN
NO20034453L (en) Use of CD25-binding molecules in steroid-resistant patients
JP2006199620A (en) Cosmetic obtained by applying silicon compound and its manufacturing method
Juzans et al. Enhancement of quantal acetylcholine release and selective depletion of clear synaptic vesicules from motor nerve terminals poisoned with a peptide isolated from the venom of the stone fish (Synanceia trachynis)
ATE496628T1 (en) USE OF LECITHIN AS A MEDICINE TO TREAT PSORIASIS

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees